Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6410.0000
51.00
(
0.80
%)
NSE
Nov 25, 2025
15:14 PM
29.36% Gain from 52W Low
Volume:
152.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
29 May 2017
6410.00
0.80%
Divis Laboratories Ltd Q4FY17 results comment
Results Update:
Divi's Laboratories Ltd.
by
HDFC Securities
HDFC Securities
Revenue increased by 9.21% to Rs. 1063.14 Cr in Q4FY17 when compared to the previous quarter.
Divi's Laboratories .. has an
average target
of 6432.50 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market trades higher, LIC acquires a 2% stake in Voltas
Trendlyne Marketwatch |
25 Nov 2025, 03:05PM
Which stocks did superstar investors sell in Q2FY26?
The Baseline |
24 Nov 2025, 04:46PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022